Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 31, 2025

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

434

Microfluidic systems for cancer diagnostics.

Jose L Garcia-Cordero1, Sebastian J Maerkl2

  • 1Unidad Monterrey, Centro de Investigación y de Estudios Avanzados del IPN (Cinvestav-IPN), Nuevo León, Mexico.

Current Opinion in Biotechnology
|January 1, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A T7 RNAP regulatory toolbox for cell-free network engineering and biosensing applications.

Nature communications·2026
Same author

PURE makes PURE: reconstitution of the PURE cell-free system from self-synthesized proteins.

Nature communications·2026
Same author

Integrated Microfluidic Platform for High-Throughput Generation of Intestinal Organoids in Hydrogel Droplets.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Microfluidics meets cell-free systems: from molecular engineering to synthetic cells.

Current opinion in biotechnology·2025
Same author

Integrating microfluidic automation into thermoplastic devices for analysis of small volumes of blood.

Biosensors & bioelectronics·2025
Same author

Evolving infectious disease dynamics shape school-based intervention effectiveness.

Nature communications·2025
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Microfluidic systems offer advanced cancer diagnostics and prognosis by analyzing biomarkers in liquid biopsies. These technologies promise more sensitive and precise cancer detection, paving the way for personalized therapies.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Nanotechnology

Background:

  • Microfluidic systems are emerging as a pivotal technology for cancer diagnostics and prognosis.
  • They enable the analysis of critical cancer biomarkers such as circulating tumor cells, cell-free DNA, exosomes, and proteins.
  • These systems primarily utilize liquid biopsies (serum, plasma, whole blood), circumventing the need for invasive tumor tissue biopsies.

Purpose of the Study:

  • To summarize technological advances in microfluidics for cancer diagnosis, prognosis, and monitoring.
  • To highlight the potential of microfluidics in enabling personalized cancer therapies.
  • To discuss future evolutionary steps for microfluidic technologies in oncology.

Main Methods:

  • Review of current microfluidic technological advancements in cancer biomarker analysis.

More Related Videos

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.6K
Microfluidic Applications for Disposable Diagnostics
10:21

Microfluidic Applications for Disposable Diagnostics

Published on: February 3, 2008

9.3K

Related Experiment Videos

Last Updated: Dec 31, 2025

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
09:45

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology

Published on: November 14, 2025

434
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.6K
Microfluidic Applications for Disposable Diagnostics
10:21

Microfluidic Applications for Disposable Diagnostics

Published on: February 3, 2008

9.3K
  • Focus on applications in liquid biopsies for detecting circulating tumor cells, cell-free DNA, exosomes, and proteins.
  • Integration of microfluidic devices with biosensors for enhanced detection sensitivity and precision.
  • Main Results:

    • Microfluidic devices show significant promise for sensitive and precise detection of cancer biomarkers.
    • Integrated microfluidic technologies coupled with biosensors outperform conventional assays in certain cancer biomarker detections.
    • These advancements are crucial for monitoring cancer progression, recurrence, and guiding personalized treatment strategies.

    Conclusions:

    • Microfluidic systems are poised to become a cornerstone technology in clinical cancer diagnostics and prognosis.
    • The continuous progress in microfluidics is driving the development of more effective and personalized cancer therapies.
    • Future research will likely focus on further refining sensitivity, integration, and clinical translation of these powerful diagnostic tools.